Endovia and Lupvindol BioSciences Announce FDA Determination that CannEpil® for Canine Bone Cancer Pain Qualifies as a Minor Use, Establishing Eligibility for Conditional Approval Pathway
Endovia Health Sciences to Meet Formally with FDA’s Center for Veterinary Medicine on November 19th for Pre-Submission Conference